Evolved By Nature Closes USD120M Series C Funding

Evolved By Nature, a Boston, MA-based company creating a proprietary library of Activated Silk™ molecules from natural silk protein, closed a $120M Series C financing.

The round was led by Teachers’ Venture Growth, part of the C$242 billion Ontario Teachers’ Pension Plan Board, and Senator Investment Group, with participation from existing investors including Mousse Partners, Chanel, Jeff Vinik, The Kraft Group, Roy Disney and Emerald Development Managers.

The company intends to use the funds to accelerate commercialization of the Activated Silk™ technology platform, which will move global markets away from dependence on synthetics and fossil fuel derivatives and expand the boundaries of regenerative medicine.

Founded in 2013 by Dr. Greg Altman, CEO, and Dr. Rebecca Lacouture, President, COO, Evolved By Nature is a biotechnology company that creates renewably sourced solutions to human health needs. Activated Silk biotechnology leverages natural silk protein to create sustainable molecules with the potential to protect, repair, and enhance the barrier function of anything with a surface. This enables the next generation of products within textiles, personal care, aesthetic and medical treatments, therapeutics and more. 

In the last year, Evolved by Nature’s biodegradable, high-performance finishes have been adopted by fashion brands including Anya Hindmarch, nylon mills including Alpine Creations and Apex Holdings, and leather tanneries including Richard Hoffmans GmbH & Co. KG, Cyclica Srl and Curtidos Bengala.

The round coincides with the launch of a full-scale manufacturing facility in Walpole, Massachusetts, which will ramp up production volumes to 900 metric tons of Activated Silk™ per year.